Insider Trading activities of Rexahn Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rexahn Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rexahn Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Rexahn Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is RNN. The reporting company's CIK number is 1228627.
The total value of stock buying since 2005 is $2,158,187.
The total value of stock sales since 2005 is $2,805,545.
The total value of stock option exercises since 2005 is $827,995.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Rexahn Pharmaceuticals, Inc. (RNN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-04 0 $0 250,000 $175,500 250,000 $77,500
2015-01 0 $0 631,928 $575,918 631,928 $505,541
2014-06 0 $0 136,193 $134,422 136,193 $108,954
2014-04 0 $0 0 $0 125,000 $100,000
2013-09 0 $0 71,139 $32,510 150,000 $36,000
2011-10 2,500 $2,600 0 $0 0 $0
2011-09 150,000 $171,355 0 $0 0 $0
2011-05 1,008,078 $1,320,582 0 $0 0 $0
2011-04 320,846 $391,432 0 $0 0 $0
2009-07 5,600 $4,480 0 $0 0 $0
2009-05 260,000 $176,800 2,600,000 $1,768,000 0 $0
2008-05 3,000 $6,750 0 $0 0 $0
2008-04 36,000 $84,188 0 $0 0 $0
2006-12 0 $0 384,500 $119,195 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Rexahn Pharmaceuticals, Inc. insiders (RNN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-04-10 Ahn Chang Ho Sale 250,000 .70 175,500
2017-04-10 Ahn Chang Ho Option Ex 250,000 .31 77,500
2015-01-12 Jeong Tae Heum (Chief Financial Officer) Sale 49,800 .91 45,517
2015-01-12 Jeong Tae Heum (Chief Financial Officer) Option Ex 49,800 .80 39,840
2015-01-12 Ahn Chang Ho Sale 48,444 .91 44,277
2015-01-12 Ahn Chang Ho Option Ex 48,444 .80 38,755
2015-01-09 Jeong Tae Heum (Chief Financial Officer) Sale 188,690 .92 172,651
2015-01-09 Jeong Tae Heum (Chief Financial Officer) Option Ex 188,690 .80 150,952
2015-01-09 Ahn Chang Ho Sale 186,212 .92 170,570
2015-01-09 Ahn Chang Ho Option Ex 186,212 .80 148,969
2015-01-08 Jeong Tae Heum (Chief Financial Officer) Sale 78,782 .90 70,903
2015-01-08 Jeong Tae Heum (Chief Financial Officer) Option Ex 78,782 .80 63,025
2015-01-08 Ahn Chang Ho Sale 80,000 .90 72,000
2015-01-08 Ahn Chang Ho Option Ex 80,000 .80 64,000
2014-06-12 Ahn Chang Ho Sale 136,193 .99 134,422
2014-06-12 Ahn Chang Ho Option Ex 136,193 .80 108,954
2014-04-14 Mcintosh David M Option Ex 125,000 .80 100,000
2013-09-09 Jeong Tae Heum (Chief Financial Officer) Sale 71,139 .46 32,510
2013-09-09 Jeong Tae Heum (Chief Financial Officer) Option Ex 150,000 .24 36,000
2011-10-03 Kivel Richard Buy 2,500 1.04 2,600
2011-09-09 Brandt Peter C. Buy 80,000 1.22 97,600
2011-09-08 Brandt Peter C. Buy 45,000 1.10 49,635
2011-09-07 Brandt Peter C. Buy 5,000 1.04 5,200
2011-09-06 Brandt Peter C. Buy 20,000 .95 18,920
2011-05-18 Ahn Chang Ho (Chairman & CEO) Buy 1,008,078 1.31 1,320,582
2011-04-01 Ahn Chang Ho (Chairman & CEO) Buy 320,846 1.22 391,432
2009-07-30 Mcintosh David M Buy 5,600 .80 4,480
2009-05-04 Ahn Chang Ho (Chairman & CEO) Buy 260,000 .68 176,800
2009-05-04 Ahn Chang Ho (Chairman & CEO) Sale 2,600,000 .68 1,768,000
2008-05-05 Cheong Kwang Soo Buy 3,000 2.25 6,750
2008-04-24 Kang Y Michele Buy 2,000 2.35 4,700
2008-04-23 Kang Y Michele Buy 8,000 2.32 18,568
2008-04-22 Jeong Tae Heum (CFO) Buy 5,000 2.17 10,850
2008-04-14 Hoffman Freddie Ann Buy 1,000 2.20 2,200
2008-04-14 Ahn Chang Ho (Chairman & CEO) Buy 10,000 2.37 23,670
2008-04-08 Beever Charles Buy 10,000 2.42 24,200
2006-12-11 Park Young Soon (Director) Sale 384,500 .31 119,195

Insider trading activities including stock purchases, stock sales, and option exercises of RNN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rexahn Pharmaceuticals, Inc. (symbol RNN, CIK number 1228627) see the Securities and Exchange Commission (SEC) website.